Ahren Lp investment portfolio

Biomodal develops omics‑based life‑science technology and analytics products that provide single‑base‑resolution sequencing and multi‑omics solutions, extracting detailed genetic and epigenetic information from low‑input DNA samples. Its offerings serve researchers and developers working on cancer, neurodegenerative disease and ageing.

Bitfount offers a federated, privacy‑preserving platform that lets organisations run AI, machine‑learning and analytics on data without moving or exposing the raw data. Its services target life‑science and health‑care stakeholders—including pharma companies, CROs, hospitals, researchers and model developers—to enable secure data collaborations, clinical‑trial analytics, and data‑consortia projects.